Clinical Trials · NCT01714843
A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 559
- Start date
- Aug 2012
- Locations
- 4 sites, Japan
- Primary endpoint
- Global assessment of relief of IBS symptoms Responder